Want to join the conversation?
Ravi Fadah of William Blair probes on the growth for implants in 1Q16. $XRAY said implant is a strategic fulcrum for the company. The company is well positioned with its product offerings there. $XRAY believes this is a category that will continue to grow. Rest of World did better in implants; volume was up.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?